8
Participants
Start Date
January 31, 2014
Primary Completion Date
January 31, 2016
Study Completion Date
January 31, 2016
Lixisenatide
"Lixisenatide and placebo are considered as investigational medicinal product (IMP). Metformin is not considered an investigational product but concomitant allowed antidiabetic medications.~Lixisenatide is supplied as disposable pre-filled pen for subcutaneous injection: 10mcg Lixisenatide green pens; 20 mcg Lixisenatide purple pens. Dose titration-10mcg Lixisenatide for 14 days, 20 mcg for 14 days."
Placebo
Placebo for lixisenatide is supplied as green and purple colored disposable pen-injectors containing 3 mL of a sterile aqueous solution.
University of Surrey FHMS Diabetes and Metabolic Medicine, Guildford
Collaborators (1)
Sanofi
INDUSTRY
University of Surrey
OTHER